Covered recipient · General Payments record
ADAM BELLAMY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$255.60
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.88 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $85.69 | 4 |
| Xeris Pharmaceuticals, Inc. | $44.55 | 2 |
| Amgen Inc. | $43.30 | 2 |
| Exact Sciences Corporation | $20.40 | 1 |
| ABBVIE INC. | $17.51 | 1 |
| PFIZER INC. | $16.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.51 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103304008 | CMS |
| Amgen Inc. | $23.62 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117201257 | CMS |
| Amgen Inc. | $19.68 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111527592 | CMS |
| Exact Sciences Corporation | $20.40 | 05/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114589163 | CMS |
| GlaxoSmithKline, LLC. | $20.17 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116446788 | CMS |
| GlaxoSmithKline, LLC. | $20.72 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116278634 | CMS |
| GlaxoSmithKline, LLC. | $17.34 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115784622 | CMS |
| GlaxoSmithKline, LLC. | $27.46 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116513115 | CMS |
| PFIZER INC. | $16.43 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131988683 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.58 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144584880 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.97 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144584882 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.